| Manager | Title | Age | Since |
|---|---|---|---|
Ola Holmlund
CEO | Chief Executive Officer | 57 | 01/01/2018 |
Jan Holmbäck
CTO | Chief Tech/Sci/R&D Officer | 69 | 01/01/2010 |
Charlotta Ekman
DFI | Director of Finance/CFO | 45 | 01/10/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Ola Flink
CHM | Chairman | 82 | 01/01/2017 |
| Chairman | 46 | 01/01/2020 | |
Gunilla Lundmark
BRD | Director/Board Member | 63 | 01/06/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -98.73% | - | - | 92.63K | |
| -0.03% | -2.25% | +48.55% | +88.64% | 1,001B | |
| -0.20% | -3.41% | +48.93% | +63.43% | 642B | |
| +1.00% | +0.47% | +17.00% | +72.88% | 451B | |
| -0.38% | -3.59% | +28.24% | +35.57% | 340B | |
| -0.09% | -13.54% | +10.08% | +26.87% | 263B | |
| -0.43% | -2.48% | -2.07% | +11.48% | 247B | |
| -0.87% | -13.22% | +34.21% | +44.98% | 207B | |
| -3.44% | -7.51% | -20.08% | -59.58% | 197B | |
| -0.51% | -4.66% | +22.14% | +86.86% | 180B | |
| Average | -0.47% | -5.53% | +20.78% | +41.24% | 391.82B | |
| Weighted average by Cap. | -0.25% | -4.65% | +30.20% | +55.99% |
Employees
4
Sector
Pharmaceuticals
